Galderma’s Melasma Cream Now at Pharmacies

Melasma causes the appearance of brown to gray-brown patches of skin due to the body producing too much melanin, a natural substance that gives color to skin, hair and eyes. Melasma usually appears on the face, although it can also develop on the forearms and neck.

Tri-Luma Cream combines three active ingredients:fluocinolone acetonide 0.01%, a mild corticosteroid that reduces inflammation; hydroquinone 4%, a de-pigmenting agent that interrupts the formation and synthesis of melanin to help lighten the skin; and tretinoin 0.05%, which works to increase the skin cell turnover rate to exfoliate skin. There is no generic equivalent.

There are many factors that are associated with melasma including the use of birth control pills, hormone therapy, cosmetics and anti-seizure medications. Because melasma is so common during pregnancy, it is sometimes referred to as “the mask of pregnancy.”

“Tri-Luma is the only FDA-approved product containing hydroquinone 4% to treat melasma patients safely and effectively. At Galderma we engage with doctors to develop an empathetic understanding of melasma and the impact it has on patients. Our greatest satisfaction comes from the realization that Tri-Luma can actually help people and positively change their lives,” explains Francois Fournier, president of Galderma’s US and Canadian Operations. “Galderma is more than ever committed to delivering innovative medical solutions to meet the dermatological needs of patients throughout their lifetime while serving healthcare professionals.”